The Global Opioid Induced Constipation Treatment Market size is projected to reach USD 3093.7 million by 2028, from USD 981.8 million in 2020, at a CAGR of 17% during 2022-2028.
Opioid-induced constipation (OIC) is a type of secondary disorder associated with long-term use of opioids. Opioids include substances such as methadone, oxycodone, codeine, and morphine. These substances relieve pain by slowing the central nervous system. The central nervous system is responsible for the body’s response to pain. However, the central nervous system also regulates body movements, including involuntary movements that enable digestion. Therefore, the use of opioids can cause constipation.
(Get 15% Discount on Buying this Report)
A full report of Global Opioid Induced Constipation Treatment Market is available at: https://orionmarketreports.com/opioid-induced-constipation-treatment/82796/
Market Segments
By Drug Class
- Mu-Opioid Receptor Antagonist
- Locally Acting Chloride Channel Activator
- Peripherally-Restricted Mu-opioid Receptor Antagonist
- Non-selective Opioid Antagonist
By Mode of Administration
- Oral
- bowel movements
- Parenteral
- abdominal pain
Key Players
- GlaxoSmithKline
- AstraZeneca
- Pfizer
- S.L.A. Pharma
- AIKO Biotechnology
- Cubist Pharmaceuticals
- Salix Pharmaceuticals
- Takeda Pharmaceutical
Scope of the Report
The research study analyzes the global Opioid Induced Constipation Treatment industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Opioid Induced Constipation Treatment Market Report
1. What was the Opioid Induced Constipation Treatment Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).
2. What will be the CAGR of Opioid Induced Constipation Treatment Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Opioid Induced Constipation Treatment Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Opioid Induced Constipation Treatment market.
- The market share of the global Opioid Induced Constipation Treatment market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the global Opioid Induced Constipation Treatment market.
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Opioid Induced Constipation Treatment market.
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
